Caitlin John’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.7K Sell
53
-1
-2% -$1.02K 0.03% 328
2026
Q1
$49.7K Buy
54
+7
+15% +$7.1K 0.03% 311
2025
Q4
$50.5K Sell
47
-73
-61% -$69.8K 0.03% 312
2025
Q3
$91.5K Buy
+120
New +$89.3K 0.06% 195
2025
Q1
Sell
-56
Closed -$43K 502
2024
Q4
$43K Sell
56
-25
-31% -$20.7K 0.03% 250
2024
Q3
$65.5K Buy
81
+41
+103% +$36.9K 0.04% 208
2024
Q2
$35.9K Sell
40
-18
-31% -$14.4K 0.03% 291
2024
Q1
$44.8K Sell
58
-3
-5% -$2.13K 0.03% 251
2023
Q4
$35.3K Buy
+61
New +$35.6K 0.03% 258

Other funds holding LLY

Caitlin John's LLY Position: Q2 2026 in Review

Caitlin John reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $1.02K and leaving 53 shares worth $63.7K. The position accounts for 0.03% of the portfolio, ranked #328.

Caitlin John first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $91.5K in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Caitlin John held 53 shares of Eli Lilly worth $63.7K as of Q2 2026.
  • Caitlin John sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.03% of Caitlin John's portfolio in Q2 2026, its #328 holding.
  • Caitlin John first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • Caitlin John's Eli Lilly position peaked at $91.5K in Q3 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.